This series brings to the reader a comprehensive view of the current global scenario of the pharma industry. India and China are big markets, after the US and Europe. Vol. I includes five articles on the US, Europe, India and China and a perspective on Asia. Case studies on Pfizer, GlaxoSmithKline, Ranbaxy and Cipla also feature here.
ABOUT THE AUTHOR K. Krishnaphani
Krishnaphani Kesiraju (b.1957) is a graduate in mechanical engineering and holds an MBA degree in Finance from Osmania University, Hyderabad. He also holds a Bachelor's Degree in Law from Kakatiya University, Warangal. He has more than 23 years of work experience. He worked for Andhra Bank for 16 years, mostly in the area of industrial credit covering micro, small, medium and large enterprises. He has seven years of experience as a consultant for project finance. He has been a guest/adjunct faculty at a business school in Hyderabad for several years, teaching finance. His areas of interest are banking, industrial finance and project management. He is at present working as a faculty member and consulting editor at ICFAI Books. He has edited five other books, "Bancassurance: An Introduction", "Credit Derivatives: An Introduction","Pension Systems: A New Focus", "Pharma Sector: Trends and Cases - Vol.I", and "Pharma Sector: Trends and Cases - Vol.II", published by ICFAI Books, an affiliate of the ICFAI University.
There are no reviews yet.